Covered recipient · General Payments record
ANNE E EYLER
Allopathic & Osteopathic Physicians Internal Medicine Rheumatology
General Payments · PY2018–2021
$514.62
- Reported across 32 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2021 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $140.16 | 8 |
| Education | $30.00 | 2 |
By paying entity
PY2021 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $53.51 | 3 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $46.08 | 2 |
| Amgen Inc. | $30.00 | 2 |
| Horizon Pharma plc | $27.82 | 2 |
| Flexion Therapeutics, Inc. | $12.75 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2021 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AbbVie Inc. | $13.68 | 03/11/2021 | Food and Beverage | Undisputed | 01/23/2026 | 794426539 | CMS |
| AbbVie Inc. | $19.49 | 06/02/2021 | Food and Beverage | Undisputed | 01/23/2026 | 794426543 | CMS |
| AbbVie Inc. | $20.34 | 07/14/2021 | Food and Beverage | Undisputed | 01/23/2026 | 794426547 | CMS |
| Amgen Inc. | $15.00 | 01/07/2021 | Education | Undisputed | 01/23/2026 | 826295417 | CMS |
| Amgen Inc. | $15.00 | 01/26/2021 | Education | Undisputed | 01/23/2026 | 826295421 | CMS |
| Horizon Therapeutics plc | $13.71 | 05/17/2021 | Food and Beverage | Undisputed | 01/23/2026 | 797120527 | CMS |
| Horizon Therapeutics plc | $14.11 | 07/29/2021 | Food and Beverage | Undisputed | 01/23/2026 | 797120531 | CMS |
| Novartis Pharmaceuticals Corporation | $24.16 | 05/25/2021 | Food and Beverage | Undisputed | 01/23/2026 | 812673711 | CMS |
| Novartis Pharmaceuticals Corporation | $21.92 | 12/06/2021 | Food and Beverage | Undisputed | 01/23/2026 | 812673713 | CMS |
| Pacira Therapeutics, Inc. | $12.75 | 04/22/2021 | Food and Beverage | Undisputed | 01/23/2026 | 838719421 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021
- Generated from
- OP_DTL_GNRL_PGYR2021_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.